Trial Profile
A Multicenter, Randomized, Vehicle-Controlled, Efficacy and Safety Study of CD2027 3 microg/g Oily Spray Applied Twice Daily for 8 Weeks in Subjects With Plaque-Type Psoriasis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2022
Price :
$35
*
At a glance
- Drugs Calcitriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Galderma
- 27 Oct 2009 New trial record.